264 related articles for article (PubMed ID: 31751390)
1. Drug resistance and epidemiology characteristics of multidrug-resistant tuberculosis patients in 17 provinces of China.
Lu Z; Jiang W; Zhang J; Lynn HS; Chen Y; Zhang S; Ma Z; Geng P; Guo X; Zhang H; Zhang Z
PLoS One; 2019; 14(11):e0225361. PubMed ID: 31751390
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the socio-demographic and clinical features of pulmonary TB patients infected with sub-lineages within the W-Beijing and non-Beijing Mycobacterium tuberculosis.
Hu Y; Mathema B; Zhao Q; Zheng X; Li D; Jiang W; Wang W; Xu B
Tuberculosis (Edinb); 2016 Mar; 97():18-25. PubMed ID: 26980491
[TBL] [Abstract][Full Text] [Related]
3. Cross-sectional Whole-genome Sequencing and Epidemiological Study of Multidrug-resistant Mycobacterium tuberculosis in China.
Huang H; Ding N; Yang T; Li C; Jia X; Wang G; Zhong J; Zhang J; Jiang G; Wang S; Zong Z; Jing W; Zhao Y; Xu S; Chen F
Clin Infect Dis; 2019 Jul; 69(3):405-413. PubMed ID: 30321294
[TBL] [Abstract][Full Text] [Related]
4. [Prevalence and risk factors on the resistance related to second-line drugs among multi-drug resistant tuberculosis cases in Shanghai, China].
Li J; Zhang YY; Gui XH; Yuan ZA; Pan QC; Mei J; Shen X
Zhonghua Liu Xing Bing Xue Za Zhi; 2012 Aug; 33(8):796-8. PubMed ID: 22967331
[TBL] [Abstract][Full Text] [Related]
5. Drug Resistance Characteristics of
Wu X; Yang J; Tan G; Liu H; Liu Y; Guo Y; Gao R; Wan B; Yu F
Front Cell Infect Microbiol; 2019; 9():345. PubMed ID: 31828045
[No Abstract] [Full Text] [Related]
6. Prevalence and molecular characteristics of drug-resistant Mycobacterium tuberculosis in Beijing, China: 2006 versus 2012.
Yin QQ; Jiao WW; Li QJ; Xu F; Li JQ; Sun L; Li YJ; Huang HR; Shen AD
BMC Microbiol; 2016 May; 16():85. PubMed ID: 27176471
[TBL] [Abstract][Full Text] [Related]
7. Primary and secondary anti-tuberculosis drug resistance in Hitossa District of Arsi Zone, Oromia Regional State, Central Ethiopia.
Hamusse SD; Teshome D; Hussen MS; Demissie M; Lindtjørn B
BMC Public Health; 2016 Jul; 16():593. PubMed ID: 27430266
[TBL] [Abstract][Full Text] [Related]
8. Isolation of Mycobacterium tuberculosis from sputum of tribal, non-tribal pulmonary tuberculosis patients of Andaman & Nicobar islands by conventional culture method and assessment of first line anti-tuberculosis drug susceptibility patterns.
Mandal A; Parthasarathy G; Burma SP; Sugunan AP; Vijayachari P
Indian J Tuberc; 2015 Jan; 62(1):23-8. PubMed ID: 25857562
[TBL] [Abstract][Full Text] [Related]
9. Value of pyrazinamide for composition of new treatment regimens for multidrug-resistant Mycobacterium tuberculosis in China.
Xia H; van den Hof S; Cobelens F; Zhou Y; Zhao B; Wang S; Zhao Y
BMC Infect Dis; 2020 Jan; 20(1):19. PubMed ID: 31910878
[TBL] [Abstract][Full Text] [Related]
10. High incidence of drug-resistant Mycobacterium tuberculosis in Hainan Island, China.
Lin M; Zhong Y; Chen Z; Lin C; Pei H; Shu W; Pang Y
Trop Med Int Health; 2019 Sep; 24(9):1098-1103. PubMed ID: 31278806
[TBL] [Abstract][Full Text] [Related]
11. Molecular characterization of mutations associated with resistance to second-line tuberculosis drug among multidrug-resistant tuberculosis patients from high prevalence tuberculosis city in Morocco.
Oudghiri A; Karimi H; Chetioui F; Zakham F; Bourkadi JE; Elmessaoudi MD; Laglaoui A; Chaoui I; El Mzibri M
BMC Infect Dis; 2018 Feb; 18(1):98. PubMed ID: 29486710
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of drug resistant Mycobacterium tuberculosis among children in China.
Jiao WW; Liu ZG; Han R; Zhao XQ; Dong F; Dong HY; Huang HR; Li QJ; Lin N; Song WQ; Wan KL; Shen AD
Tuberculosis (Edinb); 2015 May; 95(3):315-20. PubMed ID: 25814302
[TBL] [Abstract][Full Text] [Related]
13. [A survey on resistance to second-line drugs in patients with pulmonary tuberculosis in Shanghai, China].
Shen X; Li J; Gao Q; Xu B; Mei J
Zhonghua Jie He He Hu Xi Za Zhi; 2011 Jun; 34(6):451-3. PubMed ID: 21781519
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for extensive drug resistance in multidrug-resistant tuberculosis cases: a case-case study.
Guglielmetti L; Veziris N; Aubry A; Brossier F; Bernard C; Sougakoff W; Jarlier V; Robert J
Int J Tuberc Lung Dis; 2018 Jan; 22(1):54-59. PubMed ID: 29297426
[TBL] [Abstract][Full Text] [Related]
15. Additional Drug Resistance Patterns among Multidrug-Resistant Tuberculosis Patients in Korea: Implications for Regimen Design.
Mok JH; Kang BH; Lee T; Lee HK; Jang HJ; Cho YJ; Jeon D
J Korean Med Sci; 2017 Apr; 32(4):636-641. PubMed ID: 28244290
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of multidrug-resistant pulmonary tuberculosis in counties with different duration of DOTS implementation in rural China.
Hu Y; Mathema B; Wang W; Hoffner S; Kreiswirth B; Xu B
Microb Drug Resist; 2008 Sep; 14(3):227-32. PubMed ID: 18707239
[TBL] [Abstract][Full Text] [Related]
17. Additional Drug Resistance in Patients with Multidrug-resistant Tuberculosis in Korea: a Multicenter Study from 2010 to 2019.
Lee T; Lee SJ; Jeon D; Lee HY; Kim HJ; Kang BH; Mok J
J Korean Med Sci; 2021 Jul; 36(26):e174. PubMed ID: 34227261
[TBL] [Abstract][Full Text] [Related]
18. Predictor of multidrug resistant tuberculosis in southwestern part of Ethiopia: a case control study.
Gobena D; Ameya G; Haile K; Abreha G; Worku Y; Debela T
Ann Clin Microbiol Antimicrob; 2018 Jul; 17(1):30. PubMed ID: 29970076
[TBL] [Abstract][Full Text] [Related]
19. Trends in drug-resistant tuberculosis in China: data from a clinical tuberculosis centre.
Liao S; Cai C; Huo FM; Wu JN; Kong CC; Huang HR; Xu SF; Sun ZG
Int J Tuberc Lung Dis; 2017 Sep; 21(9):990-995. PubMed ID: 28826447
[TBL] [Abstract][Full Text] [Related]
20. Primary drug resistance of mycobacterium tuberculosis in Shandong, China, 2004-2018.
Song WM; Li YF; Ma XB; Liu JY; Tao NN; Liu Y; Zhang QY; Xu TT; Li SJ; Yu CB; Gao L; Cui LL; Li HC
Respir Res; 2019 Oct; 20(1):223. PubMed ID: 31627757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
